Hasten, Orbital Raise 2023’s Biggest Venture Capital Rounds Days Apart
Larger VC Rounds Emerge Following Quiet First Quarter
Hasten brought in $315m, and Orbital garnered $270m, but while multiple venture firms have raised large new funds, Q1 saw the lowest amount of biopharma VC fundraising in a single quarter since 2019.
